Essex Financial Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $233K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $223K | Buy |
|
|||||
|
2024
Q3 | $212K | Sell |
|
|||||
|
2024
Q2 | $285K | Buy |
|
|||||
|
2024
Q1 | $219K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $258K | Buy |
|
|||||
|
2022
Q1 | $241K | Buy |
|
|||||
|
2021
Q4 | $244K | Buy |
|
|||||
|
2021
Q3 | $206K | Sell |
|
|||||
|
2021
Q2 | $229K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $203K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $328K | Buy |
|
|||||
|
2019
Q3 | $297K | Sell |
|
|||||
|
2019
Q2 | $280K | Buy |
|
|||||
|
2019
Q1 | $281K | Buy |
|
|||||
|
2018
Q4 | $256K | Sell |
|
|||||
|
2018
Q3 | $324K | Buy |
|
|||||
|
2018
Q2 | $320K | Buy |
|
|||||
|
2018
Q1 | $302K | Buy |
|
|||||
|
2017
Q4 | $252K | Sell |
|
|||||
|
2017
Q3 | $331K | Buy |
|
|||||
|
2017
Q2 | $348K | Buy |
|
|||||
|
2017
Q1 | $318K | Sell |
|
|||||
|
2016
Q4 | $334K | Sell |
|
|||||
|
2016
Q3 | $402K | Buy |
|
|||||
|
2016
Q2 | $399K | Sell |
|
|||||
|
2016
Q1 | $406K | Sell |
|
|||||
|
2015
Q4 | $437K | Sell |
|
|||||
|
2015
Q3 | $476K | Sell |
|
|||||
|
2015
Q2 | $558K | Sell |
|
|||||
|
2015
Q1 | $629K | Sell |
|
|||||
|
2014
Q4 | $701K | Buy |
|
|||||
|
2014
Q3 | $475K | Hold |
|
|||||
|
2014
Q2 | $553K | Sell |
|
|||||
|
2014
Q1 | $572K | Buy |
|
|||||
|
2013
Q4 | $403K | Buy |
|
|||||
|
2013
Q3 | $221 | Sell |
|
|||||
|
2013
Q2 | $321K | Buy |
|